Category: Regulatory and Drug Development Terminology
New Drug Application
An application submitted to the US FDA seeking approval to market a drug under the applicable regulatory framework. An NDA generally contains evidence and documentation about clinical studies, manufacturing, safety, effectiveness, labeling, and other requirements relevant to the proposed indication.
- Abbreviation:
- NDA
- Updated November 3, 2026